The objective of this clinical investigation is to evaluate, in a controlled setting, the safety and performance of the BeGraft Peripheral (BGP) balloon expandable covered stent Graft System (Bentley InnoMed, Hechingen, Germany) implanted as bridging stent in FEVAR (fenestrated endovascular aortic repair) for complex aortic aneurysms.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Efficacy endpoint (1) - Technical success
Timeframe: 1 day post-op
Efficacy endpoint (2) ) Bridging stent patency at 12 months
Timeframe: 12 months post-op
Safety endpoint at 12 months
Timeframe: 12 months post-op